🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
299,00 USD
Máx. histórico
322,75
6 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-7,36%
Rango 52 semanas
175,89 – 326,63
Variación hoy
-5,42%
Cierre anterior
316,13
Rango de hoy
297,63 – 318,98
Volumen hoy
247.610
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 120,08 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 11 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 26/02/1997 | 50,53 | 50,53 | 47,72 | 47,72 | -5,56% | 5,56% | 23.591 |
| 25/02/1997 | 47,26 | 50,53 | 47,26 | 50,53 | +5,88% | 6,93% | 35.667 |
| 24/02/1997 | 47,26 | 48,66 | 46,32 | 47,72 | +0,00% | 4,95% | 39.861 |
| 21/02/1997 | 48,66 | 50,06 | 47,72 | 47,72 | -4,67% | 4,81% | 37.777 |
| 20/02/1997 | 49,59 | 50,53 | 48,66 | 50,06 | +0,94% | 3,77% | 23.297 |
| 19/02/1997 | 49,13 | 50,53 | 48,66 | 49,59 | +0,00% | 3,81% | 27.331 |
| 18/02/1997 | 50,06 | 51,00 | 48,66 | 49,59 | -2,75% | 4,67% | 25.514 |
| 14/02/1997 | 51,00 | 51,93 | 49,59 | 51,00 | +0,00% | 4,59% | 24.072 |
| 13/02/1997 | 50,06 | 52,40 | 50,06 | 51,00 | +0,93% | 4,67% | 20.305 |
| 12/02/1997 | 51,00 | 51,93 | 49,59 | 50,53 | -0,92% | 4,59% | 76.623 |
| 11/02/1997 | 51,93 | 51,93 | 51,00 | 51,00 | -1,80% | 1,80% | 44.697 |
| 10/02/1997 | 52,40 | 53,34 | 50,53 | 51,93 | +1,83% | 5,36% | 25.728 |
| 07/02/1997 | 49,59 | 51,93 | 48,66 | 51,00 | +4,81% | 6,60% | 23.992 |
| 06/02/1997 | 47,72 | 48,66 | 47,72 | 48,66 | -0,95% | 1,96% | 47.476 |
| 05/02/1997 | 49,13 | 49,59 | 47,96 | 49,13 | +0,48% | 3,33% | 50.815 |
| 04/02/1997 | 49,59 | 51,47 | 47,72 | 48,89 | -4,13% | 7,55% | 111.061 |
| 03/02/1997 | 51,93 | 52,40 | 49,59 | 51,00 | -1,80% | 5,41% | 29.255 |
| 31/01/1997 | 52,87 | 54,27 | 50,06 | 51,93 | -0,89% | 7,96% | 51.189 |
| 30/01/1997 | 52,93 | 54,27 | 52,40 | 52,40 | +0,00% | 3,54% | 23.858 |
| 29/01/1997 | 54,27 | 54,27 | 52,40 | 52,40 | -3,45% | 3,45% | 22.522 |
| 28/01/1997 | 53,34 | 54,27 | 52,87 | 54,27 | +1,75% | 2,63% | 47.716 |
| 27/01/1997 | 53,81 | 55,68 | 53,34 | 53,34 | -4,20% | 4,35% | 81.566 |
| 24/01/1997 | 55,21 | 57,08 | 53,81 | 55,68 | -0,83% | 5,93% | 31.579 |
| 23/01/1997 | 56,14 | 57,55 | 54,74 | 56,14 | +0,00% | 5,00% | 40.770 |
| 22/01/1997 | 54,27 | 58,02 | 54,27 | 56,14 | +2,56% | 6,90% | 55.651 |
| 21/01/1997 | 52,40 | 55,68 | 51,47 | 54,74 | +0,86% | 8,04% | 53.674 |
| 20/01/1997 | 56,14 | 56,61 | 52,40 | 54,27 | -2,52% | 7,50% | 53.193 |
| 17/01/1997 | 56,61 | 56,61 | 54,74 | 55,68 | -0,83% | 3,31% | 28.507 |
| 16/01/1997 | 55,68 | 57,08 | 54,74 | 56,14 | +0,84% | 4,20% | 33.476 |
| 15/01/1997 | 56,14 | 56,14 | 54,27 | 55,68 | +1,71% | 3,33% | 48.651 |